ANNUAL REPORT

Company

RELMADA THERAPEUTICS, INC.

Filed

September 24, 2019

Period of Report

June 30, 2019

Accession Number

0001213900-19-018787

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →